95% risk free3 Dec 2021 12:34
I think this week has shown us there is a little hedging/top slicing going on with the PI's, whilst the big boys continue to fill their boots. PI's maybe concerned that if Omicron proves to be mild there will be no use for SNG.
There are many reasons why I think the potential mildness of Omicron is not that relevant to this share, but the two main ones are
1. Stockpiling.... the reason I have stayed in this share for nearly two years, is because governments need to stockpile a viral agnostic as insurance against future variants and pandemics, and all the unknowns that come with them. SNG don't need big Pharma to sell to Governments, and this will be a massive income stream, direct to them, without the 85% cut that big Pharma would take.
2. As the EUA for Molnupiravir has shown us, the bar is set very low. 30% with side effects. Our Phase 2 showed 80% with no side effects. Even if Phase 3 shows 20% with no side effects, it could easily get an EUA. It's not much to ask.
I have accumulated close to 200,000 shares over the past two years. There have been some mornings when I have felt a little sick after some massive drops, but I have never doubted RM and his team.
Whatever the result, I won't be investing in a single share again.